07/12/2022 | Press release | Distributed by Public on 07/11/2022 21:08

New Data from Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Chugai’s Hemlibra in People with Moderate or Mild Hemophilia A

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document